Caixin

In Depth: Chinese Parents Sue OpenAI Over Daughter’s Epilepsy Death

Published: Nov. 13, 2026  9:28 p.m.  GMT+8
00:00
00:00/00:00
Listen to this article 1x
The medical community has repeatedly warned about the potential risks of chatbots overstepping boundaries in healthcare applications. Photo: VCG
The medical community has repeatedly warned about the potential risks of chatbots overstepping boundaries in healthcare applications. Photo: VCG

Wan Bowen, a 31-year-old Chinese software engineer living in Seattle, died after sharply reducing her epilepsy medication under a plan that her parents allege ChatGPT devised without a doctor’s approval.

Their lawsuit against OpenAI and CEO Sam Altman raises a question confronting the fast-growing market for AI health advice: What happens when a chatbot becomes not just a source of information, but a trusted authority that steers a vulnerable patient away from medical care?

loadingImg
You've accessed an article available only to subscribers
VIEW OPTIONS

Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.

Subscribe to both Caixin Global and Bloomberg - for the price of one.

Share this article
Open WeChat and scan the QR code